Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension

HypertensionThrombosis and Stroke

The Prognostic Value of Follow-up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension

Circulation.

Weatherald J, Boucly A, Chemla D, Savale L, Peng M, Jevnikar M, Jaïs X, Taniguchi Y, O'Connell C, Parent F, Sattler C, Hervé P, Simonneau G, Montani D, Humbert M, Adir Y, Sitbon O

doi: 10.1161/CIRCULATIONAHA.

Heart, Artery and Coronary DiseasesHeart FailureHypertension

Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction

JAMA Cardiol.

Vanderpool RR, Saul M, Nouraie M, Gladwin MT, Simon MA

doi: 10.1001/jamacardio.

Heart, Artery and Coronary DiseasesHypertensionTherapy and Intervention

Pulmonary Hypertension in Patients With Severe Aortic Stenosis: Prognostic Impact After Transcatheter Aortic Valve Replacement: Pulmonary Hypertension in Patients Undergoing TAVR

JACC Cardiovasc Imaging.

Alushi B, Beckhoff F, Leistner D, Franz M, Reinthaler M, Stähli BE, Morguet A, Figulla HR, Doenst T, Maisano F, Falk V, Landmesser U, Lauten A

doi: 10.1016/j.jcmg.2018.02.015.

Heart FailureHypertension

Right Heart End-Systolic Remodeling Index Strongly Predicts Outcomes in Pulmonary Arterial Hypertension: Comparison With Validated Models

Circ Cardiovasc Imaging.

Amsallem M, Sweatt AJ, Aymami MC, Kuznetsova T, Selej M, Lu H, Mercier O, Fadel E, Schnittger I, McConnell MV, Rabinovitch M, Zamanian RT, Haddad F

doi: 10.1161/

Hypertension

Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER Study

Hypertension.

Williams B, Cockcroft JR, Kario K, Zappe DH, Brunel PC, Wang Q, Guo W

doi: 10.1161/

Hypertension

Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary Study

Hypertension.

Ghazi L, Cohen LP, Muntner P, Shimbo D, Drawz PE

doi: 10.1161/HYPERTENSIONAHA.

Heart FailureHypertensionVentricular Function

Pulmonary Hypertension in Heart Failure: Pathophysiology, Pathobiology, and Emerging Clinical Perspectives

J Am Coll Cardiol.

Guazzi M, Naeije R

doi: 10.1016/j.jacc.2017.01.051.

Cardiovascular Risk and DiseasesHeart, Artery and Coronary DiseasesHeart FailureHypertension

Prognostic Value of Echocardiography in Hypertensive Versus Nonhypertensive Participants From the General Population

Hypertension

Modin D, Biering-Sørensen SR, Mogelvang R, Landler N, Jensen JS, Biering-Sørensen T

doi: 10.1161/

Hypertension

Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates

ESC Heart Fail

Tavares-Silva M, Saraiva F, Pinto R, Amorim S, Silva JC, Leite-Moreira AF, Maciel MJ, Lourenço AP

doi: 10.1002/ehf2.13168

Related content

The Prognostic Value of Follow-up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension

Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction

Pulmonary Hypertension in Patients With Severe Aortic Stenosis: Prognostic Impact After Transcatheter Aortic Valve Replacement: Pulmonary Hypertension in Patients Undergoing TAVR

Right Heart End-Systolic Remodeling Index Strongly Predicts Outcomes in Pulmonary Arterial Hypertension: Comparison With Validated Models

Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER Study

Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary Study

Pulmonary Hypertension in Heart Failure: Pathophysiology, Pathobiology, and Emerging Clinical Perspectives

Prognostic Value of Echocardiography in Hypertensive Versus Nonhypertensive Participants From the General Population

Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates